Researchers used 3D imaging and AI to map over 10 million oligodendrocytes in mouse brains, revealing regional myelin patterns relevant to neurological disease.
Key Details
- 1Johns Hopkins team mapped over 10 million oligodendrocytes in each mouse brain using 3D imaging, tissue clearing, and light-sheet microscopy.
- 2Machine learning was used to automatically identify and catalog cells, creating detailed maps of cell locations and gene expression.
- 3Maps showed regional differences—areas with more direct sensory input had three times more oligodendrocytes than others.
- 4Myelin formation and oligodendrocyte addition varied by brain region and over the lifespan, following a rigid developmental program.
- 5Damaged myelin was more vulnerable near amyloid plaques in a mouse Alzheimer's model and in certain brain regions after induced injury.
- 6Data and maps are freely available for researchers, aiming to accelerate further discoveries in brain disorders.
Why It Matters
This work combines AI and imaging to reveal new insights into myelin's role in brain function and vulnerability in neurological disease, offering high-resolution tools for studying conditions like MS and Alzheimer's. Freely accessible maps may propel new advances in neuroimaging and radiology research.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.